Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3.
Year: 2000
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: J C Gutheil, T N Campbell, P R Pierce, J D Watkins, W D Huse, D J Bodkin, D A Cheresh
Institution: Sidney Kimmel Cancer Center
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2109069224